Home > Analytics > WINDLAS BIOTECH

WINDLAS BIOTECH
Intrinsic Value | Fundamental Analysis

BOM : 543329     NSE : WINDLAS    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : NA
Feb 06,2023
Price(EOD): ₹ 241.40
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 516.60 Cr
Value of ₹ 1 Lac invested in WINDLAS BIOTECH
on Aug 16,2021 (price: ₹ 406.70)

₹ 1 L

₹ 0.59 L

1W : -1.8% 1M : -1.4% 1Y : -10.5%
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results
WINDLAS BIOTECH is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
WINDLAS BIOTECH -1.8% -1.4% -10.5%
SUN PHARMACEUTICAL INDUSTRIES -1.1% 0.8% 15.6%
DIVIS LABORATORIES -16.3% -19.7% -31.6%
CIPLA 1.3% -5.4% 7.5%
DR REDDYS LABORATORIES 0.6% 1.3% -1.3%
TORRENT PHARMACEUTICALS 1.2% -1.3% 12%
ABBOTT INDIA 0.2% -5.5% 28.7%
ZYDUS LIFESCIENCES 9.2% 8.7% 4.7%
ALKEM LABORATORIES 2% 0.9% -14%

FUNDAMENTAL ANALYSIS OF WINDLAS BIOTECH

 
Fundamentals Score
[ Q(TTM): Sep2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF WINDLAS BIOTECH

 
Valuation Score
[As on : Feb 06,2023 ]

Ratio Consolidated
P/E
P/B
P/S
11.45
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 45.10 Cr
[Latest Qtr - Sep2022 - Consolidated Results ]

1.31
P/B Calculated based on Book Value of Rs 392.97 Cr
[Latest Year - Mar2022 - Consolidated Results ]

1.05
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 492.39 Cr
[Latest Qtr - Sep2022 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 29% undervalued companies ! Discover More →

FAIR VALUE OF WINDLAS BIOTECH

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
166%
171%
-2%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF WINDLAS BIOTECH



WINDLAS BIOTECH vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF WINDLAS BIOTECH

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.02
0.16
0.12
0.1
0.02
0.16
0.13
0.1
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF WINDLAS BIOTECH

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF WINDLAS BIOTECH

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
10.67%
16.34%
15.44%
24.43%
15.17%
21.97%
43.93%
46.92%
QtrlyTrend
8
Latest Qtr: Sep2022
Quarterly Result Analysis →


WINDLAS BIOTECH related INDICES

BSE Indices1W1M1Y
S&P BSE SMALL CAP 1.5% -3.4% -5.1%
S&P BSE MIDSMALLCAP 1.5% -3% -3.2%
S&P BSE ALLCAP 0.5% -3.1% -1.2%
S&P BSE HEALTHCARE -1.6% -3.6% -9.4%
No NSE index found

You may also like the below Video Courses


FAQ about WINDLAS BIOTECH


Is WINDLAS BIOTECH good for long term investment?

As on Feb 06,2023, the Fundamentals of WINDLAS BIOTECH look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of WINDLAS BIOTECH . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is WINDLAS BIOTECH UnderValued or OverValued?

As on Feb 06,2023, WINDLAS BIOTECH is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of WINDLAS BIOTECH ?

As on Feb 06,2023, the Intrinsic Value of WINDLAS BIOTECH is Rs. 90.67 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 90.67
Fair Value [Median EV / Sales Model] : Rs. 89.01
Fair Value [Median Price / Sales Model] : Rs. 246.61
Estimated Median Fair Value of WINDLAS BIOTECH : Rs. 90.67

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is WINDLAS BIOTECH trading at a Premium or Discount?

As on Feb 06,2023, WINDLAS BIOTECH is trading at a Premium of 166% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].